Patent Issued for Prediction of tissue irregularities based on biomarker monitoring (USPTO 12011163).

Cilag GmbH International has been issued a patent for a system that predicts tissue irregularities during surgery based on biomarker measurements. The system uses a computing system to monitor a patient's biomarkers and predict potential complications. The biomarkers used for prediction include tissue perfusion pressure, lactate, oxygen saturation, respiration rate, and more. Based on the predicted complications, the system generates control signals to adjust surgical parameters and improve outcomes. This patent provides a new approach to enhancing surgical procedures by utilizing biomarker monitoring. [Extracted from the article]

Copyright of Medical Devices & Surgical Technology Week is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)